CompanyDrug

Alphamab Oncology and CSPC Pharma Get Green Light for KN026 Phase III Study in Breast Cancer

CompanyDrug

Eyenovia, Inc. Receives FDA Approval for Mydcombi, a First-of-Its-Kind Ophthalmic Spray

DrugPolicy / Regulatory

NMPA Releases 67th Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances SHR-1819, SHR-2002, and Adebrelimab into New Clinical Trials

CompanyDrug

Ascletis Pharma Receives Approval for Phase IIa Study of ASC10 for RSV Infection

CompanyDeals

EQRx Inc. Abandons Plans for Low-Cost Drugs, Terminates Development of Three China-Sourced Products

CompanyDeals

Shunxi Holding Group Secures Licensing Deal for Cartherics’ CTH-004 in Greater China

CompanyDrug

AstraZeneca’s MEK Inhibitor Koselugo Approved in China for Pediatric NF1-Related PN

CompanyDeals

Shenzhen’s Angio8 Secures Tens of Millions in Series A Financing for Surgical Robot Development

CompanyDrug

BeiGene’s Brukinsa Receives NMPA Approval for Expanded Use in Leukemia and Lymphoma

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Shows Promise in Phase III Study for ES-SCLC

Policy / Regulatory

Tianjin, Shandong, and Hainan Provinces Announce VBP Backup Suppliers for Round 8